The British wife of ousted Syrian dictator Bashar al-Assad is deathly ill with leukemia — with doctors only giving her a 50% chance of survival, according to a report.
“Asma is dying,” one source recently in direct contact with a family representative told the Telegraph of 49-year-old Asma al-Assad.
The former first lady is being cared for in Moscow — where her husband fled after his regime was toppled earlier this month — where she is being cared for mostly by her father, cardiologist Fawaz Akhras, who is “heartbroken,” the source said.
She is so sick “she can’t be in the same room” with hardly anyone else, the source said.
“She has been 50/50 in the last few weeks,” another source said doctors’ predictions on her chances of survival.
Asma al-Assad previously had breast cancer, which went away after a year of treatment, officials announced in 2019.
The former Syrian government then revealed in May that Asma had been diagnosed with acute myeloid leukemia – a cancer that affects the bone marrow and blood.
That also went into remission, until reappearing again recently, the UK paper reported.
“When leukemia comes back, it’s vicious,” one of the paper’s sources said.
Assad, who was born in London, is believed to have flown to the Russian capital before her husband was urged to leave the country he led for nearly 25 years.
Her “heartbroken” father, a cardiologist, has been caring for his daughter over the past six months — first in the United Arab Emirates and later in Moscow, The Telegraph reported.
News of her deteriorating condition emerged following rumors that she has filed for divorce from her husband and wants to go to the UK with her children — which the Kremlin immediately denied.
The Turkish media report claimed she filed for divorce just two weeks after her family fled Syria ahead of a rebel advance into Damascus.
Asma was reportedly fed up with Russian restrictions that confined her and her three children to the city of Moscow, and she wants access to top-quality cancer treatment, according to the reports.
